神経感染症

抽象的な

Roles of New Drugs in Neuroimaging

Robert Gilman

New molecular imaging approaches have helped to close the divide between preclinical and clinical studies. Imaging strategies have advanced significantly in the last decade as a result of advances in modern imaging scanners, prescription drug production, screening agents, and new clinical regimens, many of which have resulted in substantial changes in health care. The information gleaned from imaging methods in preclinical studies can be applied to patients. Similarly, complications discovered in human clinical trials will be examined and researched in preclinical experiments. In conclusion, neuroimaging continues to advance and expand, adopting emerging developments and addressing ever more complex and relevant neuroscience issues.